View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 3, 2022

Swift Medical introduces imaging device to treat skin and wound conditions

The device’s imaging capabilities can detect complications on any skin tone, allowing clinicians to treat all patients equally.

Digital wound care management technology company Swift Medical has introduced a new medical imaging device, Swift Ray 1, to treat skin and wound conditions.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Claimed to be the world’s first all-in-one hyperspectral imaging device, it attaches wirelessly to a smartphone camera and captures complete clinical data for patients in order to support treatment, assessment and monitoring of skin and wound conditions.

Regardless of skin tone, Swift Ray 1 allows clinicians to treat all patients equally with its imaging capabilities that enable the detection of complications on any skin tone.

It helps to examine the important physiological characteristics of a wound that indicate cause for concern and/or improper healing, such as signs of tissue compromise, inflammation, perfusion, infection, bacterial colonisation and blood oxygen levels.

Using near-infrared, long-wave infrared, ultraviolet and improved RGB imaging technology, the Swift Ray 1 illuminates invisible, beneath-the-skin characteristics.

Swift Medical co-founder and CEO Carlo Perez said: “The future of wound care goes beyond what the naked eye can perceive and beyond the walls of the clinic, which is why our dream has always been to equalise and improve healthcare access for humanity through intelligent diagnostics.

“The Swift Ray 1 gets us one step closer by helping clinicians and patients see below the surface of the skin, to heal wounds faster or prevent them from ever even developing.”

The new device works with the company’s wound management software app.

This allows clinicians to capture and share images of a patient’s wound in order to provide accessible, efficient and preventive care.

The company stated that Swift Ray 1 helps in the identification of wound infections and inhibited wound healing, as well as the early detection of deep tissue injuries and prevention of pressure injuries.

It also supports the monitoring of chronic wound patients remotely in the home.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network